1-12 of 12
Ming-hui Duan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Clinical Trials & Observations
Hao Zhao, Miao-yan Zhang, Kai-ni Shen, Jun Feng, Xin-xin Cao, Ming-hui Duan, Dao-bin Zhou, Lu Zhang, Jian Li
Journal: Blood
Blood (2023) 141 (21): 2654–2657.
https://doi.org/10.1182/blood.2023020009
Published: 2023
Includes: Supplemental data
Journal Articles

The Design of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea (HU)

Jie Jin, Lei Zhang, Su-Jiang Zhang, Suning Chen, Ming-hui Duan, Jingjing Zhang, Wei Wang, Warren Shen, Oleh Zagrijtschuk, Raymond Urbanski, Albert Qin, Zhijian Xiao
Journal: Blood
Blood (2021) 138 (Supplement 1): 4628.
https://doi.org/10.1182/blood-2021-146449
Published: 2021
Journal Articles

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Paola Guglielmelli, MD, Jean-Jacques Kiladjian, MD PhD, Alessandro M. Vannucchi, MD, Ming-hui Duan, MD, Haitao Meng, MD PhD, Ling Pan, MD PhD, Guangsheng He, MD PhD, Srdan Verstovsek, MD PhD, Françoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Dietger Niederwieser, MD PhD, Anna Marina Liberati, MD, Claire Harrison, DM, FRCP, FRCPath, Pantelia Roussou, MSc, Monika Wroclawska, MD, Kevin Majidi, Peter AW te Boekhorst, MD PhD, Heinz Gisslinger, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-137742
Published: 2020
Journal Articles

Treatment Outcome and Prognostic Factors for Adult Langerhans Cell Histiocytosis

Xinxin Cao, MD, Ming-hui Duan, MD, Ai-lin Zhao, Hao Cai, Jia Chen, Xue-min Gao, Ting Liu, Hua-cong Cai, MD, Lu Zhang, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
https://doi.org/10.1182/blood-2020-138426
Published: 2020
Journal Articles

A Prospective, Multicenter Study of Bortezomib, Cyclophosphamide and Dexamethasone in Relapsed/Refractory Idiopathic Multicentric Castleman's Disease

Lu Zhang, MD, Ming-nan Jia, MD, Ai-lin Zhao, MD, Jun Feng, MD, Xin-xin Cao, MD, Yan Zhang, MD, Ming-hui Duan, MD, Dao-Bin Zhou, Yujun Dong, MD, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-140115
Published: 2020
Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2127.
https://doi.org/10.1182/blood-2019-125505
Published: 2019
Journal Articles

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Xinxin Cao, Jian Li, MD, Ai-lin Zhao, Xue-min Gao, Hua-cong Cai, MD, Lu Zhang, MD, Yan Zhang, MD, Jun Feng, MD, Miao Chen, MD, Tie-nan Zhu, MD, Na Niu, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Ming-hui Duan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 294.
https://doi.org/10.1182/blood-2019-122220
Published: 2019
Journal Articles

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Clinical Trials & Observations
Lu Zhang, Ai-lin Zhao, Ming-hui Duan, Zhi-yuan Li, Xin-xin Cao, Jun Feng, Dao-bin Zhou, Ding-rong Zhong, David C. Fajgenbaum, Jian Li
Journal: Blood
Blood (2019) 133 (16): 1720–1728.
https://doi.org/10.1182/blood-2018-11-884577
Published: 2019
Journal Articles

Clinical and PET Responses to Long-Term High-Dose Interferon-α Treatment Among Patients with Erdheim-Chester Disease

Xinxin Cao, Na Niu, Jian Sun, Hao Cai, Feng-dan Wang, Yi-ning Wang, Ding-rong Zhong, Ming-hui Duan, MD, Dao-bin Zhou, MD, Jian Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5215.
https://doi.org/10.1182/blood-2018-99-114040
Published: 2018
Journal Articles

Peritransplant Complications and Long-Term Outcomes of Patients with Newly Diagnosed POEMS Syndrome after Upfront Autologous Stem Cell Transplantation

Jian Li, MD, Ming-hui Duan, MD, Wei Zhang, MD, Chen Wang, MD, Xu-fei Huang, MD, Tie-nan Zhu, MD, Hua-cong Cai, MD, Xin-xin Cao, MD, Dao-bin Zhou, MD
Journal: Blood
Blood (2016) 128 (22): 2259.
https://doi.org/10.1182/blood.V128.22.2259.2259
Published: 2016
Journal Articles

Evaluation of Clinicopathologic Characteristics and the BRAF V600E Mutation in Erdheim-Chester Disease Among Chinese Adults

Xin-xin Cao, MD, Jian Sun, MD, Jian Li, MD, Ding-rong Zhong, MD, Na Niu, Bachelor, Ming-hui Duan, MD, Zhi-yong Liang, MD, Dao-bin Zhou, MD
Journal: Blood
Blood (2015) 126 (23): 3870.
https://doi.org/10.1182/blood.V126.23.3870.3870
Published: 2015
Journal Articles

Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome

Clinical Trials & Observations
Jian Li, Wei Zhang, Li Jiao, Ming-Hui Duan, Hong-Zhi Guan, Wei-Guo Zhu, Zhuang Tian, Dao-Bin Zhou
Journal: Blood
Blood (2011) 117 (24): 6445–6449.
https://doi.org/10.1182/blood-2010-12-328112
Published: 2011